Mizuho Issues Pessimistic Forecast for Ventas (NYSE:VTR) Stock Price

Ventas (NYSE:VTR – Get Free Report) had its target price dropped by equities research analysts at Mizuho from $104.00 to $101.00 in a note issued to investors on Monday, Benzinga reports. The firm presently has an “outperform” rating on the real estate investment trust’s stock. Mizuho‘s price target suggests a potential upside of 13.25% from the stock’s previous close.

Other analysts have also recently issued research reports about the stock. BNP Paribas Exane upped their target price on shares of Ventas from $93.00 to $110.00 and gave the company an “outperform” rating in a research note on Thursday, July 30th. UBS Group increased their price objective on Ventas from $90.00 to $99.00 and gave the stock a “neutral” rating in a research note on Wednesday, November 11th. Weiss Ratings cut shares of Ventas from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Tuesday, November 3rd. BMO Capital Markets boosted their price objective on Ventas from $105.00 to $107.00 and gave the stock an “outperform” rating in a research note on Tuesday, August 11th. Finally, Wells Fargo & Company increased their price objective on shares of Ventas from $96.00 to $102.00 and gave the stock an “overweight” rating in a report on Monday. Seventeen analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. According to MarketBeat.com, Ventas currently has an average rating of “Moderate Buy” and a consensus price target of $99.82.

View Our Latest Analysis on Ventas

Ventas Stock Up 0.3%

NYSE:VTR traded up $0.27 during mid-day trading on Monday, reaching $89.19. The stock had a trading volume of 642,322 shares, compared to its average volume of 3,628,257. The business’s 50 day moving average is $86.40 and its 200 day moving average is $87.03. The company has a debt-to-equity ratio of 0.78, a current ratio of 0.43 and a quick ratio of 0.43. Ventas has a fifty-two week low of $73.82 and a fifty-two week high of $101.60. The stock has a market cap of $47.16 billion, a P/E ratio of 168.23, a PEG ratio of 3.64 and a beta of 0.77.

Ventas (NYSE:VTR – Get Free Report) last announced its quarterly earnings results on Tuesday, October 27th. The real estate investment trust reported $0.13 EPS for the quarter, missing the consensus estimate of $0.98 by ($0.85). Ventas had a net margin of 3.86% and a return on equity of 1.86%. The company had revenue of $1.83 billion for the quarter, compared to analyst estimates of $1.77 billion. During the same quarter last year, the business earned $0.88 EPS. The company’s revenue for the quarter was up 23.0% on a year-over-year basis. As a group, sell-side analysts predict that Ventas will post 3.89 earnings per share for the current year.

Institutional Inflows and Outflows

Several large investors have recently added to or reduced their stakes in VTR. BlackRock Inc. bought a new stake in shares of Ventas during the 2nd quarter worth approximately $4,953,439,000. Dimensional Fund Advisors LP grew its position in shares of Ventas by 3.6% in the 1st quarter. Dimensional Fund Advisors LP now owns 7,190,594 shares of the real estate investment trust’s stock valued at $588,045,000 after acquiring an additional 253,019 shares during the period. Legal & General Group Plc acquired a new position in shares of Ventas during the 2nd quarter worth about $501,850,000. Deutsche Bank AG bought a new stake in shares of Ventas in the 2nd quarter valued at about $451,822,000. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its holdings in shares of Ventas by 5.5% in the 2nd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 4,981,404 shares of the real estate investment trust’s stock valued at $442,349,000 after purchasing an additional 258,859 shares during the period. Institutional investors and hedge funds own 94.18% of the company’s stock.

Ventas Company Profile

(Get Free Report)

Ventas, Inc. is a real estate investment trust focused on properties and services that support the health care and senior living sectors. Its portfolio includes senior housing communities, outpatient medical buildings, and research and life science facilities. The company owns and invests in properties across the United States, Canada, and the United Kingdom. Many of its communities and facilities are operated by health care and senior living providers, while Ventas provides real estate capital and asset management.

Further Reading

Analyst Recommendations for Ventas (NYSE:VTR)

Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.